SCHEMBL5659701

SCHEMBL5659701

Cc1cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(c3ccccc3Cl)c3ccccc32)cc(C)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.44
CNR1 P21554 2/20 0.40
GPR55 Q9Y2T6 2/20 0.40
MGLL Q99685 1/20 0.39
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
XBP1 P17861 1/20 0.35
PKM P14618 1/20 0.35
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14457628 0.88 ELANE (0.43) CNR1GPR55MGLLALDH1A1MAPT
SCHEMBL5661596 0.84 CNR1 (0.42) PGRCNR1GPR55ALDH1A1MAPT
SCHEMBL30929657 0.84 CNR1 (0.42) PGRCNR1GPR55ALDH1A1MAPT
SCHEMBL5659374 0.82 PGR (0.42) PGRCNR1GPR55ALDH1A1MAPT
SCHEMBL5658731 0.81 CNR1 (0.52) CNR1GPR55ALDH1A1MAPTKDM4E
SCHEMBL5662233 0.80 HSP90AA1 (0.41) CNR1GPR55MGLLALDH1A1MAPT
SCHEMBL5661614 0.80 ALDH1A1 (0.46) CNR1GPR55ALDH1A1MAPTKDM4E
SCHEMBL5659726 0.80 TP53 (0.52) CNR1GPR55ALDH1A1MAPTSMN1; SMN2
SCHEMBL5660585 0.78 PGR (0.46) PGRCNR1GPR55MGLLALDH1A1
SCHEMBL5657006 0.78 MGLL (0.40) CNR1GPR55MGLLALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 PGR 186/4885CNR1 362/4885GPR55 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.